David Kirn, Chief Executive Officer at 4D Molecular Therapeutics, Inc. (FDMT), sold 184,002 shares at $27.13 ($5.0M) on 2024-02-08, disclosed to the SEC on 2024-02-12.
Scheduled sale ($5.0M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.13 | 92,001 | $2.5M | 50.0% |
| 2 | $27.13 | 92,001 | $2.5M | 50.0% |
| Total | $27.13 avg | 184,002 | $5.0M | 100% |
| Filing → |
| FDMT | SELL | 2026-08-21 | $1.1M | — | Filing → |
| FDMT | SELL | 2026-08-05 | $275K | — | Filing → |
| FDMT | SELL | 2026-08-04 | $125K | — | Filing → |